
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Infection with a strain of HIV already resistant to one or more antiretroviral drugs does not necessarily result in more rapid disease progression, according to a study in the January 1 edition of the journal AIDS. The researchers followed about 300 HIV patients, 10% of whom were infected with drug-resistant strains of virus. They found no difference in the likelihood of suppressing HIV viral levels to below 500 through tailored drug regimens between patients with drug-resistant infections and those still responsive to all anti-HIV drugs. CD4-cell counts did fall more rapidly in the first year after infection among individuals with drug-resistant virus, but CD4-cell drop-offs occurred at similar rates in subsequent years. At the five-year mark following infection, median CD4-cell counts were similar among all study subjects.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video
Latest Stories
‘Kokomo City’ Gives a Searing Look Into Lives of Black Trans Sex Workers
August 18 2023 12:40 PM